Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HPGDS | O60760 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.36 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | RET | P07949 | 1/20 | 0.35 |
| ▸ | KDR | P35968 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14629946 | 0.80 | MAPT (0.35) | KMT2AALDH1A1LMNAMEN1SMN1; SMN2 | |
| SCHEMBL6378864 | 0.76 | ALDH1A1 (0.44) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL6070489 | 0.74 | KMT2A (0.44) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL26097101 | 0.73 | TSHR (0.54) | KMT2ARAB9AALDH1A1LMNAMEN1 | |
| SCHEMBL17428294 | 0.73 | KMT2A (0.54) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL17431466 | 0.72 | RAB9A (0.50) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL8198297 | 0.71 | ALDH1A1 (0.43) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL8194555 | 0.71 | ALDH1A1 (0.43) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL4575750 | 0.71 | ALDH1A1 (0.43) | KMT2ARAB9AALDH1A1KDM4ELMNA | |
| SCHEMBL4391703 | 0.71 | KMT2A (0.43) | KMT2ARAB9AALDH1A1KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2734507-B1 | PROCESS FOR THE SYNTHESIS OF N-SUBSTITUTED CYCLIC ALKYLENE UREAS | ALLNEX IP S À R L (LU) | 2017-05-31 | — | — | EP | claimed |
| US-20140179931-A1 | Process for the Synthesis of N-Substituted Cyclic Alkylene Ureas | ALLNEX USA INC. (US) | 2014-06-26 | — | — | US | claimed |
| EP-2734507-B1 | PROCESS FOR THE SYNTHESIS OF N-SUBSTITUTED CYCLIC ALKYLENE UREAS | ALLNEX IP S À R L (LU) | 2017-05-31 | — | — | EP | disclosed |
| US-9440928-B2 | Process for the synthesis of N-substituted cyclic alkylene ureas | Allnex IP S.ar.L. (LU) | 2016-09-13 | — | — | US | disclosed |
| US-20140179931-A1 | Process for the Synthesis of N-Substituted Cyclic Alkylene Ureas | ALLNEX USA INC. (US) | 2014-06-26 | — | — | US | disclosed |
| EP-2734507-A1 | PROCESS FOR THE SYNTHESIS OF N-SUBSTITUTED CYCLIC ALKYLENE UREAS | Allnex IP S.à.r.l. (LU) | 2014-05-28 | — | — | EP | disclosed |
| WO-2013012995-A1 | PROCESS FOR THE SYNTHESIS OF N-SUBSTITUTED CYCLIC ALKYLENE UREAS | CYTEC TECHNOLOGY CORP. (US) | 2013-01-24 | — | — | WO | disclosed |
| EP-2548869-A1 | Process for the Synthesis of N-substituted Cyclic Alkylene Ureas | Cytec Technology Corp. (US) | 2013-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140179931-A1 | Process for the Synthesis of N-Substituted Cyclic Alkylene Ureas | CA4, CA2, CDYL | KMT2A 996/4885RAB9A 4534/4885ALDH1A1 1609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.